DOI: https://doi.org/10.36347/sjmcr.2025.v13i03.006

Pages: 349-358

Verneuil's disease or hidradenitis suppurativa is a chronic inflammatory and suppurative, fistulizing and sclerosing disease of the pilosebaceous follicles of the anatomical regions rich in apocrine glands. The disease was named by Verneuil, a French surgeon, who in 1864 argued that the initial phenomenon was an inflammation of the sweat glands. This is a rare condition whose incidence has not been clearly established; the prevalence varies from 0.03% to 8% in industrialized countries. The pathophysiology of Verneuil's disease is still subject to much controversy. Studies demonstrate the presence of multiple risk factors associated with Verneuil's disease: smoking and obesity are the two main risk factors. Its positive diagnosis remains clinical, however there are many differential diagnoses, hence the interest in the para-clinical assessment and in particular the anatomo-pathological study to allow the discernment of these diagnoses. Although the prognosis is rarely life-threatening, some complications can be serious, both locally (malignant degeneration) and generally, where we note the importance of the psychological and socio-professional impact due to unsightly scars. On the therapeutic level, the care is multidisciplinary but not consensual, it advocates curbing the flare-ups and treating the lesions formed with the aim of greater comfort for the patient. The objective of this case report is to shed light on this rare disease, on its epidemiological, clinical, and therapeutic aspects, through the study of the management of a case of Verneuil's disease operated on in our plastic surgery department of the Mohamed VI University Hospital in Tangier and through a review of the literature.